NOVO NORDISK BECOMES A PARTNER OF THE VI ALL-RUSSIAN GMP CONFERENCE WITH INTERNATIONAL PARTICIPATION
Novo Nordisk is a global pharmaceutical company founded in Denmark in 1923 and the world’s leader in the development and manufacture of drugs for the treatment of diabetes and obesity.…